Welcome to our dedicated page for ECOLAB SEC filings (Ticker: ECL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ecolab Inc. filings document the public-company disclosures of a Delaware operating company whose common stock trades on the New York Stock Exchange under ECL. The filings cover operating and financial results, supplemental segment reporting, changes to reportable segment structure, capital-structure information and material-event reports.
Proxy and 8-K filings describe annual-meeting matters, board and executive-leadership changes, compensation and governance topics, and shareholder voting materials. Other disclosures address material agreements, restructuring and exit-cost matters associated with the One Ecolab initiative, business context for water, hygiene and infection prevention operations, and the company’s service footprint across multiple customer industries.
A Form 144 for Ecolab reports a proposed Rule 144 sale of 12,951 common shares through Merrill Lynch on the NYSE with an aggregate market value of $3,525,480.00. The filing lists total shares outstanding as 283,624,912 and an approximate sale date of 08/14/2025.
The shares were acquired as RSUs from Ecolab on 11/30/2018 and the payment is listed as cash. The filing reports no securities sold in the past three months and includes the standard attestation that the seller does not possess undisclosed material adverse information.